Main Plant Extracts' Active Properties Effective on Scopolamine-Induced Memory Loss (Q39153824)

9 September 2017

1 reference

title

Main Plant Extracts' Active Properties Effective on Scopolamine-Induced Memory Loss (English)

1 reference

9 September 2017

1 reference

Ioana-Miruna Balmus

1

1 reference

9 September 2017

Alin Ciobica

series ordinal

2

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

American Journal of Alzheimer's Disease & Other Dementias

9 September 2017

published in

1 reference

9 September 2017

page(s)

1533317517715906

1 reference

The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Obstacles and opportunities in Alzheimer's clinical trial recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The importance of neuritic plaques and tangles to the development and evolution of AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The cholinergic hypothesis of Alzheimer's disease: a review of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Alzheimer mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

RBC acetyl cholinesterase: A poor man's early diagnostic biomarker for familial alzheimer's and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Multiple combinations of co-factors produce variants of age-related cognitive decline: a theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Revisiting the cholinergic hypothesis in the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The role of pharmacognosy in modern medicine and pharmacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Potential medicinal plants for CNS disorders: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Noradrenergic and cholinergic systems in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Memory and cognitive function in man: Does the cholinergic system have a specific role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Distinct roles of bulbar muscarinic and nicotinic receptors in olfactory discrimination learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Rapid antidepressant effects: moving right along

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effects of cyclazocine and scopolamine on swim-to-platform performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Water maze versus radial maze: differential performance of rats in a spatial delayed match-to-position task and response to scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Motor activity changes and conditioned taste aversions induced by administration of scopolamine in rats: role of the area postrema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Cholinergic function and intellectual decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Deficits in conditioned heart rate and taste aversion in area postrema-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The effects of physostigmine and scopolamine on recognition memory in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Enhancements of choline acetyltransferase activity and nerve growth factor secretion by Polygalae radix-extract containing active ingredients in Kami-untan-to

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

The ameliorating effects of the cognitive-enhancing Chinese herbs on scopolamine-induced amnesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Hypericum extract and hyperforin: memory-enhancing properties in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Memory enhancing activity of Glycyrrhiza glabra in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Nardostachys jatamansi improves learning and memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Anti-amnestic activity of pseudocoptisine from Corydalis Tuber.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Protection against brain tissues oxidative damage as a possible mechanism for the beneficial effects of Rosa damascena hydroalcoholic extract on scopolamine induced memory impairment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effect of Salvia miltiorrhiza root extract on brain acetylcholinesterase and butyrylcholinesterase activities, their mRNA levels and memory evaluation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Cognitive Ameliorating Effect of Acanthopanax koreanum Against Scopolamine-Induced Memory Impairment in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Prunella vulgaris L., an Edible and Medicinal Plant, Attenuates Scopolamine-Induced Memory Impairment in Rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Anthriscus nemorosa essential oil inhalation prevents memory impairment, anxiety and depression in scopolamine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Cognitive-enhancing and antioxidant activities of the aqueous extract from Markhamia tomentosa (Benth.) K. Schum. stem bark in a rat model of scopolamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Fatty acid profile, tocopherol, squalene and phytosterol content of brazil, pecan, pine, pistachio and cashew nuts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Nasal route and drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Chemical characterization and insecticidal properties of essential oils from different wild populations of Mentha suaveolens subsp. timija (Briq.) Harley from Morocco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Pharmacological and toxicological properties of Nigella sativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Novel effects of Rosa damascena extract on memory and neurogenesis in a rat model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Review on Sphaeranthus indicus Linn. (Koṭṭaikkarantai).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

Natural Products as a Source of CNS-Active Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317517715906

21 January 2018

Identifiers

DOI

10.1177/1533317517715906

1 reference

9 September 2017

1 reference